DB
Beran, David Henri
| Title | Published in | Access level | OA Policy | Year | Views | Downloads | |
|---|---|---|---|---|---|---|---|
| Managing early-onset type 2 diabetes in the individual and at the population level | Lancet | 2025 | 6 | 1 | |||
| Role of biosimilar introduction on insulin glargine prices : a retrospective analysis in 28 European countries | BMJ open | 2025 | 39 | 33 | |||
| Type 1 diabetes screening: need for ethical, equity, and health systems perspective | The Lancet. Diabetes & endocrinology | 2025 | 14 | 33 | |||
| Strengthening non-communicable disease care in all-hazards emergencies | The Lancet. Diabetes & endocrinology | 2025 | 6 | 0 | |||
| Characterising acute and chronic care needs : insights from the Global Burden of Disease Study 2019 | Nature communications | 2025 | 45 | 498 | |||
| Adapting and Accepting Type 1 Diabetes: A Qualitative Exploration of the Perspectives from People with Type 1 Diabetes from 13 Countries | Healthcare | 2025 | 51 | 115 | |||
| Marked improvement in HbA1c following introduction of biosimilar insulin to treatment regimen of children and youth with type 1 diabetes in Mali : A randomised controlled trial | Diabetic medicine | 2025 | 7 | 0 | |||
| Patient relevant outcomes for type 1 diabetes management : A qualitative evidence synthesis | Diabetic medicine | 2025 | 35 | 0 | |||
| “We feel like orphans” : listening to users’ expectations to ensure more responsive healthcare services in rural Peru | BMC health services research | 2025 | 6 | 13 | |||
| Development of a target product profile for new glucose self-monitoring technologies for use in low- and middle-income countries | PloS one | 2024 | 40 | 98 | |||
| Models of Diabetes Care in Low- and Middle-Income Countries | Textbook of diabetes | 2024 | 6 | 0 | |||
| The Lancet Diabetes & Endocrinology Commission on type 1 diabetes : looking back to move forward | The Lancet. Diabetes & endocrinology | 2024 | 43 | 0 | |||
| Co-creation process of an intervention to implement a multiparameter point-of-care testing device in a primary healthcare setting for non-communicable diseases in Peru | BMC health services research | 2024 | 36 | 95 | |||
| Ensuring sexual and reproductive healthcare services amidst a pandemic : Experiences from health workers in Lima, Peru | PLOS global public health | 2024 | 39 | 129 | |||
| User requirements for non-invasive and minimally invasive glucose self-monitoring devices in low-income and middle-income countries : a qualitative study in Kyrgyzstan, Mali, Peru and Tanzania | BMJ open | 2024 | 31 | 35 | |||
| Availability, price and affordability of insulin, delivery devices and self-monitoring blood glucose devices in Indonesia | PloS one | 2024 | 33 | 1,173 | |||
| Lack of access to insulin : undermining the Rights of the Child | The Lancet. Diabetes & endocrinology | 2024 | 35 | 43 | |||
| Involving different stakeholders in prioritising outcomes to assess healthcare systems response for type 1 diabetes management : Using co-creation approaches in Peru | The International journal of health planning and management | 2024 | 43 | 139 | |||
| Outcomes measured in studies assessing health systems interventions for type 1 diabetes management : A scoping review | Diabetic medicine | 2024 | 56 | 88 | |||
| Human resources challenges in the management of diabetes and hypertension in Mozambique | PloS one | 2024 | 40 | 139 | |||
| International Day of Charity : what does charity mean for diabetes ? | The Lancet. Diabetes & endocrinology | 2024 | 28 | 0 | |||
| White Book on type 1 Diabetes in Denmark | 2023 | 550 | 357 | ||||
| A plan to improve global type 1 diabetes epidemiology data | The Lancet. Diabetes & endocrinology | 2023 | 84 | 129 | |||
| Using Clinical Vignettes to Understand the Complexity of Diagnosing Type 1 Diabetes in Sub-Saharan Africa | Research and reports in tropical medicine | 2023 | 23 | 21 | |||
| Exploring key-stakeholder perceptions on non-communicable disease care during the COVID-19 pandemic in Kenya | The Pan African medical journal | 2023 | 283 | 83 | |||
| Addressing Non-Communicable Diseases in Primary Healthcare in Kyrgyzstan : A Study on Population' Knowledge and Behavioral Changes | International journal of public health | 2023 | 125 | 120 | |||
| Type 1 Diabetes and Health Information Systems : Lessons from Denmark | European medical journal. Diabetes | 2023 | 35 | 32 | |||
| The Burden of Type 1 and Type 2 Diabetes Among Adolescents and Young Adults in 24 Western European Countries, 1990-2019 : Results From the Global Burden of Disease Study 2019 | International journal of public health | 2023 | 41 | 217 | |||
| An Empirical Review of Key Glucose Monitoring Devices: Product Iterations and Patent Protection | Journal of diabetes science and technology | 2023 | 170 | 414 | |||
| The role of nurses in diabetes care: challenges and opportunities | The Lancet. Diabetes & endocrinology | 2023 | 88 | 0 | |||
| Implementation of a salt substitute intervention using social marketing in resourced-limited communities in Peru: a process evaluation study | Frontiers in public health | 2023 | 108 | 128 | |||
| An Online Survey of the Perceptions of Clinical and Non-Clinical Professionals on Healthcare for Non-Communicable Diseases and COVID-19 Measures During the Pandemic in Malaysia | International journal of public health | 2023 | 131 | 124 | |||
| Exploring medical students’ perceptions of family medicine in Kyrgyzstan: a mixed method study | BMC medical education | 2023 | 135 | 171 | |||
| Accès à l’insuline : le(s) rôle(s) des gouvernements | Médecine des maladies métaboliques | 2023 | 71 | 0 | |||
| A study is 21 times more likely to find unfavourable results about the nutrition label Nutri-Score if the authors declare a conflict of interest or the study is funded by the food industry | BMJ global health | 2023 | 155 | 120 | |||
| The role of non-governmental organizations in strengthening healthcare systems in low- and middle-income countries: Lessons from Santé Diabète in Mali | Global health action | 2022 | 208 | 204 | |||
| Using government data to understand the use and availability of medicines for hypertension and diabetes: lessons from Peru | Journal of pharmaceutical policy and practice | 2022 | 97 | 116 | |||
| Management of type 1 diabetes in low‐ and middle‐income countries: Comparative health system assessments in Kyrgyzstan, Mali, Peru and Tanzania | Diabetic medicine | 2022 | 231 | 173 | |||
| Burden of non-communicable diseases among adolescents aged 10–24 years in the EU, 1990–2019: a systematic analysis of the Global Burden of Diseases Study 2019 | The Lancet. Child & adolescent health | 2022 | 185 | 190 | |||
| COVID‐19's impact on type 1 diabetes management : A mixed‐methods study exploring the Peruvian experience | The International journal of health planning and management | 2022 | 42 | 187 | |||
| ISPAD Clinical Practice Consensus Guidelines 2022: Insulin treatment in children and adolescents with diabetes | Pediatric diabetes | 2022 | 204 | 0 | |||
| Changes in prevalence and the cascade of care for type 2 diabetes over ten years (2005-2015): results of two nationally representative surveys in Mozambique | BMC public health | 2022 | 107 | 76 | |||
| Caring for people with diabetes and non-communicable diseases in Ukraine: a humanitarian emergency | The Lancet. Diabetes & endocrinology | 2022 | 505 | 3 | |||
| Diabetes and the WHO Model List of Essential Medicines | The Lancet. Diabetes & endocrinology | 2022 | 171 | 0 | |||
| The insulin market reaches 100 | Diabetologia | 2022 | 171 | 170 | |||
| Health system responses for type 1 diabetes: A scoping review | Diabetic medicine | 2022 | 226 | 577 | |||
| Strategies to address non-communicable diseases in the Commonwealth of Independent States countries: a scoping review | Primary health care research & development | 2022 | 92 | 98 | |||
| Diabetes mortality and trends before 25 years of age: an analysis of the Global Burden of Disease Study 2019 | The Lancet. Diabetes & endocrinology | 2022 | 172 | 204 | |||
| EXTending availability of self-management structured EducatioN programmes for people with type 2 Diabetes in low-to-middle income countries (EXTEND) - a feasibility study in Mozambique and Malawi | BMJ open | 2021 | 345 | 312 | |||
| Reforms in medical education: lessons learnt from Kyrgyzstan | Global Health Action | 2021 | 307 | 371 | |||
| Beyond the virus: Ensuring continuity of care for people with diabetes during COVID-19 | Primary Care Diabetes | 2021 | 410 | 203 | |||
| To tackle diabetes, science and health systems must take into account social context | Nature Medicine | 2021 | 228 | 145 | |||
| Process evaluation of complex interventions in chronic and neglected tropical diseases in low- and middle-income countries—a scoping review protocol | Systematic reviews | 2021 | 221 | 157 | |||
| Use of the socio-ecological model to explore factors that influence the implementation of a diabetes structured education programme (EXTEND project) inLilongwe, Malawi and Maputo, Mozambique: a qualitative study | BMC Public Health | 2021 | 302 | 280 | |||
| Operational considerations for the management of non-communicable diseases in humanitarian emergencies | Conflict and Health | 2021 | 285 | 375 | |||
| Why are individuals with diabetes less active? The mediating role of physical, emotional, and cognitive factors | Annals of Behavioral Medicine | 2021 | 268 | 1 | |||
| Development of a target product profile for a point-of-care cardiometabolic device | BMC cardiovascular disorders | 2021 | 165 | 332 | |||
| Failing to address access to insulin in its centenary year would be a catastrophic moral failure | The Lancet Diabetes & Endocrinology | 2021 | 220 | 0 | |||
| Heat-stability study of various insulin types in tropical temperature conditions: new insights towards improving diabetes care | PLOS ONE | 2021 | 392 | 421 | |||
| Access to antivenoms in the developing world: A multidisciplinary analysis | Toxicon X | 2021 | 333 | 382 | |||
| Type 1 diabetes in 2017: global estimates of incident and prevalent cases in children and adults | Diabetologia | 2021 | 240 | 390 | |||
| Forty years after Alma-Ata: primary health-care preparedness for chronic diseases in Mozambique, Nepal and Peru | Global health action | 2021 | 230 | 187 | |||
| How to bring research evidence into policy? Synthesizing strategies of five research projects in low-and middle-income countries | Health Research Policy and Systems | 2021 | 235 | 256 | |||
| Diagnostics and monitoring tools for noncommunicable diseases: a missing component in the global response | Globalization and health | 2021 | 194 | 208 | |||
| Rethinking research processes to strengthen co-production in low and middle income countries | BMJ | 2021 | 247 | 164 | |||
| A global perspective on the issue of access to insulin | Diabetologia | 2021 | 277 | 358 | |||
| Expanding access to newer medicines for people with type 2 diabetes in low-income and middle-income countries: a cost-effectiveness and price target analysis | The Lancet. Diabetes & endocrinology | 2021 | 234 | 0 | |||
| Technologies for Diabetes Self-Monitoring: A Scoping Review and Assessment Using the REASSURED Criteria | Journal of diabetes science and technology | 2021 | 199 | 192 | |||
| Precision global health: a roadmap for augmented action | Journal of Public Health and Emergency | 2020 | 1,002 | 414 | |||
| Lessons learned about co-creation: developing a complex intervention in rural Peru | Global Health Action | 2020 | 418 | 183 | |||
| Social marketing interventions for the prevention and control of neglected tropical diseases: A systematic review | PLOS Neglected Tropical Diseases | 2020 | 304 | 324 | |||
| Towards the real-time inclusion of sex- and age-disaggregated data in pandemic responses | BMJ global health | 2020 | 101 | 51 | |||
| Spotlight on experiences of medicine unavailability: access to medicines challenges for NCDs and NTDs - the contrasting cases of insulin and praziquantel | Expert Review of Clinical Pharmacology | 2020 | 295 | 2 | |||
| Nationwide survey of the availability and affordability of asthma and COPD medicines in Nigeria | Tropical Medicine & International Health | 2020 | 264 | 1 | |||
| Recommendations for the use of mathematical modelling to support decision‐making on integration of non‐communicable diseases into HIV care | Journal of the International AIDS society | 2020 | 325 | 124 | |||
| Report of the WHO independent high-level commission on NCDs: where is the focus on addressing inequalities? | BMJ (Global health) | 2020 | 253 | 159 | |||
| Global Inequality in Type 1 Diabetes: a Comparison of Switzerland and Low-and Middle-Income Countries | Pediatric endocrinology reviews : PER | 2020 | 381 | 0 | |||
| Disruption, changes, and adaptation: Experiences with chronic conditions in Mozambique, Nepal and Peru | Global Public Health | 2020 | 251 | 212 | |||
| The process of building the priority of neglected tropical diseases: A global policy analysis | PLOS Neglected Tropical Diseases | 2020 | 295 | 251 | |||
| Precios, disponibilidad y asequibilidad de insulina en farmacias públicas y privadas en Perú | Revista panamericana de salud pública | 2019 | 338 | 225 | |||
| Analogue insulin as an essential medicine: the need for more evidence and lower prices | The Lancet Diabetes & Endocrinology | 2019 | 283 | 2 | |||
| What is innovation in the area of medicines? The example of insulin and diabetes | Diabetic Medicine | 2019 | 234 | 1 | |||
| Challenges associated with providing diabetes care in humanitarian settings | The Lancet Diabetes & Endocrinology | 2019 | 360 | 1 | |||
| Forty years since Alma-Ata: do we need a new model for noncommunicable diseases? | Journal of Global Health | 2019 | 413 | 527 | |||
| Access to insulin: applying the concept of security of supply to medicines | Bulletin of the World Health Organization | 2019 | 299 | 2 | |||
| High-quality health systems: time for a revolution in research and research funding | The Lancet Global Health | 2019 | 396 | 184 | |||
| "If you will counsel properly with love, they will listen": A qualitative analysis of leprosy affected patients' educational needs and caregiver perceptions in Nepal | PLOS ONE | 2019 | 450 | 309 | |||
| Estimation of global insulin use for type 2 diabetes, 2018–30: a microsimulation analysis | The Lancet Diabetes & Endocrinology | 2019 | 293 | 1 | |||
| Insulin prices, availability and affordability in 13 low-income and middle-income countries | BMJ (Global health) | 2019 | 380 | 363 | |||
| The process of prioritization of non-communicable diseases in the global health policy arena | Health Policy and Planning | 2019 | 373 | 182 | |||
| Ability of verbal autopsy data to detect deaths due to uncontrolled hyperglycaemia: testing existing methods and development and validation of a novel weighted score | BMJ Open | 2019 | 260 | 94 | |||
| Insulin price components: case studies in six low/middle-income countries | BMJ (Global health) | 2019 | 363 | 283 | |||
| A perspective on global access to insulin: a descriptive study of the market, trade flows and prices | Diabetic Medicine | 2019 | 374 | 229 | |||
| Noncommunicable diseases, access to essential medicines and universal health coverage | Global Health Action | 2019 | 262 | 127 | |||
| Interventions targeting hypertension and diabetes mellitus at community and primary healthcare level in low- and middle-income countries:a scoping review | BMC Public Health | 2019 | 423 | 567 | |||
| The experience of the Santé Diabète NGO in the fight against diabetes in Africa | Médecine et santé tropicales | 2018 | 335 | 0 | |||
| Availability and Affordability of Essential Medicines: Implications for Global Diabetes Treatment | Current Diabetes Reports | 2018 | 286 | 1 | |||
| Déclaration de Grenoble : la lutte contre les maladies non transmissibles, dont le diabète, une urgence sanitaire pour l'Afrique | Médecine et santé tropicales | 2018 | 315 | 0 | |||
| Moving from formative research to co-creation of interventions: insights from a community health system project in Mozambique, Nepal and Peru | BMJ (Global health) | 2018 | 359 | 164 | |||
| Self-management of diabetes in Sub-Saharan Africa: a systematic review | BMC Public Health | 2018 | 299 | 209 | |||
| Accès aux soins et aux traitements pour le diabète en Afrique : défis et opportunités | Médecine et santé tropicales | 2018 | 313 | 1 | |||
| The impact of chronic disease management on primary care doctors in Switzerland: a qualitative study | BMC Family Practice | 2018 | 359 | 277 | |||
| Why Are We Failing to Address the Issue of Access to Insulin? A National and Global Perspective | Diabetes Care | 2018 | 308 | 0 | |||
| Addressing the double-burden of diabetes and tuberculosis: lessons from Kyrgyzstan | Globalization and Health | 2017 | 224 | 89 | |||
| Bringing all together for research capacity building in LMICs – Authors' reply | The Lancet Global Health | 2017 | 267 | 88 | |||
| "My heart burns" - A qualitative study of perceptions and experiences of type 1 diabetes among children and youths in Tajikistan | Chronic Illness | 2017 | 307 | 1 | |||
| The role of biosimilar manufacturers in improving access to insulin globally | The Lancet Diabetes & Endocrinology | 2017 | 234 | 0 | |||
| Diabetes in sub-Saharan Africa: from clinical care to health policy | The Lancet Diabetes & Endocrinology | 2017 | 267 | 3 | |||
| Modifying the Interagency Emergency Health Kit to include treatment for non-communicable diseases in natural disasters and complex emergencies: the missing clinical, operational and humanitarian perspectives | BMJ (Global health) | 2017 | 285 | 155 | |||
| Research capacity building—obligations for global health partners | The Lancet Global Health | 2017 | 223 | 83 | |||
| Non-communicable diseases in humanitarian settings: ten essential questions | Conflict and Health | 2017 | 403 | 268 | |||
| Towards sustainable partnerships in global health: the case of the CRONICAS Centre of Excellence in Chronic Diseases in Peru | Globalization and Health | 2016 | 237 | 137 | |||
| Integrated health systems for chronic disease management: lessons from Type 1 diabetes in Low Income Settings | 2016 | 652 | 339 | ||||
| Access to essential medicines to treat chronic respiratory disease in low-income countries | International Journal of Tuberculosis and Lung Disease | 2016 | 246 | 0 | |||
| Coping with the economic burden of Diabetes, TB and co-prevalence: evidence from Bishkek, Kyrgyzstan | BMC Health Services Research | 2016 | 436 | 199 | |||
| Insulin patents and market exclusivities: unresolved issues | The Lancet Diabetes & Endocrinology | 2016 | 211 | 0 | |||
| The need to focus on primary health care for chronic diseases | The Lancet Diabetes & Endocrinology | 2016 | 247 | 2 | |||
| Constraints and challenges in access to insulin: a global perspective | The Lancet Diabetes & Endocrinology | 2016 | 261 | 1 | |||
| Insulin in 2016: Challenge and constraints to access | Diabetes Research and Clinical Practice | 2016 | 245 | 1 | |||
| Professional medical associations in low-income and middle-income countries | The Lancet Global Health | 2016 | 229 | 112 | |||
| Delivery of Type 2 diabetes care in low- and middle-income countries: lessons from Lima, Peru | Diabetic Medicine | 2016 | 240 | 1 | |||
| Medicines availability for non-communicable diseases: the case for standardized monitoring | Globalization and health | 2015 | 603 | 326 | |||
| Diabetes in an emergency context: the Malian case study | Conflict and health | 2015 | 633 | 271 | |||
| Endemic diabetes in the world's poorest people | The Lancet. Diabetes & endocrinology | 2015 | 602 | 4 | |||
| Health systems research for policy change: lessons from the implementation of rapid assessment protocols for diabetes in low- and middle-income settings | Health research policy and systems | 2015 | 581 | 214 | |||
| In defence of NICE draft type 2 diabetes guidelines | The Lancet Diabetes & Endocrinology | 2015 | 216 | 0 | |||
| Burden of asthma and chronic obstructive pulmonary disease and access to essential medicines in low-income and middle-income countries | The Lancet. Respiratory medicine | 2015 | 707 | 3 | |||
| The Impact of Health Systems on Diabetes Care in Low and Lower Middle Income Countries | Current Diabetes Reports | 2015 | 198 | 0 | |||
| Improving global access to medicines for non-communicable diseases | The Lancet Global Health | 2014 | 209 | 105 | |||
| Use and Out-of-Pocket Costs of Insulin for Type 2 Diabetes Mellitus From 2000 Through 2010 | JAMA (Journal of the American Medical Association) | 2014 | 214 | 0 | |||
| Developing a hierarchy of needs for Type 1 diabetes | Diabetic Medicine | 2014 | 259 | 1 | |||
| The double scandal of insulin | The Journal of the Royal College of Physicians of Edinburgh | 2013 | 254 | 162 | |||
| Santé globale à l'Université de Genève : Cartographie des activités, mai 2012 | 2013 | 848 | 33 | ||||
| Diabetes in Kyrgyzstan: changes between 2002 and 2009 | The International journal of health planning and management | 2013 | 627 | 2 | |||
| Global Reality of Type 1 Diabetes Care in 2013 | Diabetes Care | 2013 | 207 | 98 | |||
| Chronic conditions: lessons from the frontlines | Chronic illness | 2013 | 585 | 2 | |||
| Non-communicable diseases in Mozambique: risk factors, burden, response and outcomes to date | Globalization and health | 2012 | 710 | 655 | |||
| Promoting the use of DPP-4 inhibitors in Asia | Diabetes research and clinical practice | 2012 | 517 | 1 | |||
| On the road to the insulin centenary | Lancet | 2012 | 511 | 1 | |||
| The International Diabetes Federation: losing its credibility by partnering with Nestlé? | Lancet | 2012 | 668 | 3 | |||
| Health systems and the management of chronic diseases: lessons from Type 1 diabetes | Diabetes management | 2012 | 647 | 0 | |||
| The insulin dilemma in resource-limited countries. A way forward ? | Diabetologia | 2011 | 13 | 90 | |||
| Twinning for better diabetes care: a model for improving healthcare for non-communicable diseases in resource-poor countries | Postgraduate medical journal | 2009 | 9 | 0 | |||
| Assessing health systems for type 1 diabetes in sub-Saharan Africa: developing a 'Rapid Assessment Protocol for Insulin Access' | BMC health services research | 2006 | 179 | 87 | |||
| Diabetes care in sub-Saharan Africa | Lancet | 2006 | 211 | 0 |
